APR 07, 2016 10:17 AM PDT

New Computer Tool Tailors Drug Dosing for Patients

WRITTEN BY: Julianne Chiaet
This image represents a compilation of schematic, patient-specific, parabolic response surfaces, which are the keys to personalized medicine. They represent responses to combination therapy for individual patients for liver transplant immunosuppression.
How much medication should you be prescribed? Everyone is born with a different body, so how much and what kind of medication needs to be tailored to you. 

For instance, after a patient has received an organ transplant, they are at risk of their body rejecting the new organ. To combat this, doctors heavily treat the patient using immunosuppressive drugs. 
 
Immunosuppressive drugs have a narrow therapeutic range. If the dose is too high, it is toxic. If the dose is too low, it could fail to keep the body from rejecting the organ. Clinicians keep a close eye on their patients and make decisions about adjusting the dose according to how they are responding the drugs. They additionally decide whether the patient needs additional medications or therapies, such as dialysis. They ultimately consider a plethora of factors before deciding on their patient’s prescription regime.  

But, when it comes down to it, those “decisions” are actually educated guesses. Doctors can’t be 100 percent sure how a patient’s body will react. After all, a patient’s ethnicity, age, genetics, and comorbidity all affect how they respond to a medication. 
 

Now, a pilot study has demonstrated the effectiveness of a computational tool that could take the guesswork out of prescribing medications for immunosuppression, cancer, heart disease, bacterial infections, and other conditions that require tightly controlled treatment regimens. The research was published on April 6, 2016, in the journal Science Translational Medicine.

The tool, called parabolic personalized dosing (PPD), uses a mathematical approach to predict the next best dose of a drug for an individual. It harnesses a patient’s clinical data, such as the drug concentration in the bloodstream, to predict the next ideal dose per patient. PPD is different from other approaches based on mathematical modeling in that it uses an algebraic equation to build a parabolic map of the patient’s response to a drug. 

In the pilot trial, UCLA researchers treated four liver transplant patients with immunosuppressant drugs using doses determined by PPD. Another group was prescribed immunosuppressant drugs using standard physician-guided dosing. The patients guided by PPD stayed within the target drug dosing range more frequently than the latter group. The PPD patients also tended to have shorter hospital stays. 

The trial showed PPD also has the potential to optimize dosing for patients using a combination of drugs. The researchers hope clinicians will use PPD in the future to automatically tailor drug dosing for a wide range of patients, including those with cancer and heart disease. 
About the Author
  • Julianne (@JuliChiaet) covers health and medicine for LabRoots. Her work has been published in The Daily Beast, Scientific American, and MailOnline. While primarily a science journalist, she has also covered culture and Japanese organized crime. She is the New York Board Representative for the Asian American Journalists Association (AAJA). • To read more of her writing, or to send her a message, go to Jchiaet.com
You May Also Like
MAR 11, 2021
Health & Medicine
Patients Lack Confidence in Their Doctor's Understanding of Cannabis
MAR 11, 2021
Patients Lack Confidence in Their Doctor's Understanding of Cannabis
Thirty-five states in the USA now have medical cannabis programs and a 2017 National Academies of Sciences, Engineering, ...
MAR 16, 2021
Clinical & Molecular DX
A Blood Test for Predicting if You'll Live to 100
MAR 16, 2021
A Blood Test for Predicting if You'll Live to 100
In 2012, a United Nations report estimated that there are over 316,000 people worldwide over the age of 100. What’ ...
MAR 22, 2021
Cell & Molecular Biology
Improving Cancer Immunotherapy While Reducing Autoimmune Side Effects
MAR 22, 2021
Improving Cancer Immunotherapy While Reducing Autoimmune Side Effects
Immunotherapy aims to make a patient's immune cells better at fighting cancer. The immune system has to be used carefull ...
MAR 25, 2021
Cardiology
Improved Triage Method to Get STEMI Patients from Door to Treatment
MAR 25, 2021
Improved Triage Method to Get STEMI Patients from Door to Treatment
A heart attack is an incredibly sudden and dangerous cardiac event that requires quick action for a successful recovery. ...
MAR 23, 2021
Coronavirus
A Mother-to-Fetus COVID-19 Transmission Has Devastating Consequences
MAR 23, 2021
A Mother-to-Fetus COVID-19 Transmission Has Devastating Consequences
A pregnant woman infected with the pandemic virus SARS-CoV-2 passed the virus on to her unborn child through the placent ...
MAR 30, 2021
Drug Discovery & Development
Common Alzheimer's Drugs Reduce Mortality Rate and Cognitive Decline
MAR 30, 2021
Common Alzheimer's Drugs Reduce Mortality Rate and Cognitive Decline
Researchers from the Karolinska Institute and Umea University in Sweden have found that a commonly recommended group of ...
Loading Comments...